Khalid Islam

Managing Director at Life Sciences Management GmbH

Khalid Islam

Khalid Islam

Managing Director at Life Sciences Management GmbH

Overview
Career Highlights

Arpida, Inc.
Gentium Srl
Arpida AG

RelSci Relationships

699

Number of Boards

19

Birthday

11/1955

Age

65

Contact Data
Trying to get in touch with Khalid Islam? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Khalid Islam likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chairman of the Board & Chief Executive Officer at Fennec Pharmaceuticals, Inc.

Relationship likelihood: Strong

Managing Partner at Kurma Biofund FCPR

Relationship likelihood: Strong

President at Gianfranco Ferro Foundation

Relationship likelihood: Strong

Co-Founder at Minoryx Therapeutics SL

Relationship likelihood: Strong

Chief Financial Officer & Principal Accounting Officer at Fennec Pharmaceuticals, Inc.

Relationship likelihood: Strong

Managing Partner at Kurma Partners SA

Relationship likelihood: Strong

Chief Executive Officer & Director at Adenium Biotech ApS

Relationship likelihood: Strong

Chief Financial Officer at Acesion Pharma ApS

Relationship likelihood: Strong

Co-Founder at Nouscom AG

Relationship likelihood: Strong

Partner, Seed Investments at Novo Holding A/S

Relationship likelihood: Strong

Paths to Khalid Islam
Potential Connections via
Relationship Science
You
Khalid Islam
Managing Director at Life Sciences Management GmbH
Education
PhD Degree
Class of 1983

Imperial College London (officially The Imperial College of Science, Technology and Medicine) is a public research university located in London, England, specialising in science, engineering, medicine and business. A former constituent college of the federal University of London, it became fully independent on 9 July 2007, as part of the celebrations of its centenary.

B.S. in Biochemistry
Class of 1977
B.S. Biochemistry

The University of London is a collegiate research university located in London, England, consisting of 18 constituent colleges, 10 research institutes and a number of central bodies. The nine largest institutions of the federal university, usually termed the colleges, are Birkbeck, Goldsmiths, King's College London, the London Business School, Queen Mary, Royal Holloway, SOAS, LSE and UCL. Formerly a constituent college, Imperial College London left the University of London in 2007.

Career History
Managing Director
2014 - Current
Partner
2009 - Current

Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland.

Advisor
Current

KP is an active manager which invest in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. KP provides financing from seed stage to growth stage capital requirements.

Boards & Committees
Chairman
1999 - 2009
Member, International Scientific Advisory Board
Current

Networks of Centres of Excellence offers programs that focuses on research and development. The company was founded in 1989 and is headquartered in Ontario, Canada.

Investments
Details Hidden

Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Khalid Islam. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Khalid Islam's profile does not indicate a business or promotional relationship of any kind between RelSci and Khalid Islam.